期刊文献+

芍药甘草汤治疗多囊卵巢综合征高雄激素血症的网络药理学研究 被引量:8

Study on the Network Pharmacology of Shaoyao Gancao Decoction in the Treatment of Hyperandrogenism in Polycystic Ovary Syndrome
下载PDF
导出
摘要 目的运用网络药理学探索芍药甘草汤对多囊卵巢综合征高雄激素血症的作用机理。方法通过TCMSP数据库结合口服生物利用度(OB)、类药性(DL)、半衰期(HL)筛选芍药甘草汤的有效活性成分及作用靶点,运用Genecards、Drugbank、OMIM数据库获取多囊卵巢综合征高雄激素血症的治疗靶点。借助Cytoscape3.7.2软件构建“中药-活性成分-靶点”可视化网络,利用VENNY图筛选出药物与疾病的共同靶点,运用STRING在线分析工具构建蛋白互作网络图(PPI),通过David数据库对关键靶点进行GO功能富集分析及KEGG通路富集分析。结果从芍药甘草汤中筛选出槲皮素、山奈酚、7-甲氧基-2-甲基异黄酮、刺芒柄花素等83个有效成分,作用于MAPK3、MMP-9、STAT3、TNF、IL-6、VEGFA等41个关键靶点。KEGG通路富集分析发现这些靶点参与了TNF、HIF-1、FoxO、Toll样受体等信号通路。结论芍药甘草汤中的槲皮素、山奈酚等可能通过TNF、IL-6、STAT3、VEGFA等靶点作用于TNF、HIF-1、FoxO、Toll样受体等信号通路来调节糖脂代谢、保护血管内皮、参与炎症反应,以减少雄激素的合成,发挥治疗多囊卵巢综合征高雄激素血症的作用。 Objective To explore the action pathway of Shaoyao Gancao Decoction on hyperandrogenism in polycystic ovary syndrome by network pharmacology.Methods The active ingredients and targets of Shaoyao Gancao Decoction were screened by TCMSP database combined with oral bioavail ability(OB),drug-like property(DL),and half-life period(HL).Genecards,Drugbank,and OMIM databases were used to obtain the targets of hyperandrogenism in polycystic ovary syndrome.Chinese medicine-active ingredient-target visualization network map was built by Cytoscape 3.7.2 software.VENNY diagram was used to screen out common targets of drugs and diseases.The protein interaction network(PPI)was constructed by STRING online analysis tool.The David database performed GO enrichment analysis and KEGG pathways analysis for key targets.Results 83 active components were screened and quercetin,kaempferol,7-methoxy-2-methyl isoflavone and formononetin were key compounds,41 key targets such as MAPK3,MMP-9,STAT3,TNF,IL-6,and VEGFA were founded.KEGG analysis indicated that these targets involved in TNF,HIF-1,FoxO,Toll-like receptors signaling pathways.Conclusion The main compounds such as quercetin,kaempferol could act on TNF,HIF-1,Toll-like receptors signaling pathways through TNF,IL-6,STAT3,VEGFA to regulate glycolipid metabolism,protect vascular endothelium and participate in inflammatory response thus reduce androgen synthesis and play a role in treating hyperandrogenism in polycystic ovary syndrome.
作者 楚丽杰 刘卉 罗文连 张涵 杨宝玉 CHU Lijie;LIU Hui;LUO Wenlian;ZHANG Han;YANG Baoyu(The First Clinical Medical College of Shandong University of Traditional Chinese Medicine,Jinan 250014,China;Department of Gynecology,Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250014,China)
出处 《云南中医学院学报》 2020年第2期84-90,共7页 Journal of Yunnan University of Traditional Chinese Medicine
基金 山东省中医药科技发展计划(2017-071)。
关键词 芍药甘草汤 高雄激素血症 多囊卵巢综合征 网络药理学 Shaoyao Gancao Decoction hyperandrogenemia polycystic ovary syndrome network pharmacology
  • 相关文献

参考文献7

二级参考文献42

  • 1王玖玲,朱敏华,李淑玲,李辉.多囊卵巢综合征患者脂联素、C反应蛋白水平的变化及其意义[J].生殖与避孕,2007,27(3):190-193. 被引量:14
  • 2黄泰康.常用中药成分与药理手册[M].北京:中国医药科技出版社,1998.1467.
  • 3金丕焕.医用统计方法[M].上海:上海医科大学出版社,1995.90-92.
  • 4竹内亨.国外医学:中医中药分册,1988,(2):48-49.
  • 5日本不妊学会杂志,1987,(4):260-260.
  • 6(日文)自和汉医药学会杂志,1986,:452-452.
  • 7刘艳巧,党慧敏,刘润侠,康晓玲.助孕胶囊对多囊卵巢大鼠血清性激素及卵巢肿瘤坏死因子α表达的影响[J].湖南中医药大学学报,2007,27(4):32-35. 被引量:8
  • 8Legro RS, Gnatuk CL, Kunselman AR, et al. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. Clin Endocrinol Metab, 2005, 90(6):3236-42.
  • 9Wild S, Pierpoint T, McKeigue P, et al. Cardiovascular disease in women with polycystic ovary syndrome at longterm fol- low-up: a retrospective cohort study. Clin Endocrinol (Oxf), 2000, 52(5):595-600.
  • 10Niwa K, Imai A, Hashimoto M, et al. A case-control study of uterine endometrial cancer of pre- and post-meno- pausal women. Dncol Rep, 2000, 7(1):89-93.

共引文献63

同被引文献212

引证文献8

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部